“Liquid elbows” due to afatinib administration

Non-small cell lung cancer adenocarcinoma in the past decade has targeted therapies as the cornerstone for therapy. In specific patients with epidermal growth factor receptor mutation have three different therapy approaches with the tyrosine kinase inhibitors: erlotinib, gefitinib and afatinib. Nowa...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Respir Med Case Rep
Glavni autori: Zarogoulidis, Paul, Chinelis, Panos, Athanasiadou, Anastasia, Porpodis, Konstantinos, Kallianos, Anastasios, Rapti, Aggeliki, Trakada, Georgia, Velentza, Lemonia, Huang, Haidong, Tsiouda, Theodora, Hohenforst-Schmidt, Wolfgang
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2017
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5491760/
https://ncbi.nlm.nih.gov/pubmed/28702338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.06.013
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items